{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Skin+Structures+and+Soft+Tissue+Infections", "query": { "condition": "Skin Structures and Soft Tissue Infections" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 10, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-05-22T02:50:24.080Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00102947", "title": "Daptomycin in the Treatment of Patients With Renal Insufficiency and Complicated Skin and Skin Structure Infections", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Soft Tissue Infections" ], "interventions": [ { "name": "daptomycin (up to 14 days)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 72, "start_date": "2005-01", "completion_date": "2006-11", "has_results": false, "last_update_posted_date": "2016-07-25", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 12, "location_summary": "Torrance, California • Tampa, Florida • Augusta, Georgia + 9 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Augusta", "state": "Georgia" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Buffalo", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00102947" }, { "nct_id": "NCT00633152", "title": "Efficacy and Safety of Ceftaroline Versus Linezolid in Subjects With Complicated Skin and Skin Structure Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Bacterial Infection" ], "interventions": [ { "name": "ceftaroline", "type": "DRUG" }, { "name": "linezolid", "type": "DRUG" }, { "name": "Aztreonam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Forest Laboratories", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 150, "start_date": "2008-02", "completion_date": "2008-07", "has_results": true, "last_update_posted_date": "2017-03-14", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 13, "location_summary": "Buena Park, California • Long Beach, California • Los Angeles, California + 10 more", "locations": [ { "city": "Buena Park", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Rolling Hills Estate", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00633152" }, { "nct_id": "NCT02607618", "title": "Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Skin Structures and Soft Tissue Infections" ], "interventions": [ { "name": "Iclaprim", "type": "DRUG" }, { "name": "Vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Motif Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 613, "start_date": "2015-11", "completion_date": "2017-08-08", "has_results": true, "last_update_posted_date": "2018-08-07", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 17, "location_summary": "Anaheim, California • Buena Park, California • Chula Vista, California + 12 more", "locations": [ { "city": "Anaheim", "state": "California" }, { "city": "Buena Park", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Palma", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02607618" }, { "nct_id": "NCT02877927", "title": "Oral Omadacycline vs. Oral Linezolid for the Treatment of ABSSSI", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Infections", "Skin Structures and Soft Tissue Infections" ], "interventions": [ { "name": "Omadacycline", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Paratek Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 735, "start_date": "2016-08", "completion_date": "2017-06-06", "has_results": true, "last_update_posted_date": "2018-11-30", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 50, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Anaheim, California + 36 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Anaheim", "state": "California" }, { "city": "Bakersfield", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02877927" }, { "nct_id": "NCT00087490", "title": "Skin Structure Infections With Suspected or Proven Methicillin-Resistant Staphylococcus Aureus (MRSA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Skin/Soft Tissue Infections", "Methicillin Resistant Staphylococcus Aureus (MRSA)" ], "interventions": [ { "name": "linezolid", "type": "DRUG" }, { "name": "vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 1077, "start_date": "2004-10", "completion_date": "2007-07", "has_results": true, "last_update_posted_date": "2012-08-08", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 76, "location_summary": "Montgomery, Alabama • Tucson, Arizona • Los Angeles, California + 53 more", "locations": [ { "city": "Montgomery", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Palm Springs", "state": "California" }, { "city": "Rancho Mirage", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00087490" }, { "nct_id": "NCT01984684", "title": "Delafloxacin vs Vancomycin and Aztreonam for the Treatment of Acute Bacterial Skin and Skin Structure Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Skin and Subcutaneous Tissue Bacterial Infections", "Skin Structures and Soft Tissue Infections" ], "interventions": [ { "name": "delafloxacin", "type": "DRUG" }, { "name": "vancomycin", "type": "DRUG" }, { "name": "aztreonam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Melinta Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 850, "start_date": "2014-05", "completion_date": "2016-01", "has_results": true, "last_update_posted_date": "2017-11-17", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 31, "location_summary": "Mobile, Alabama • Montgomery, Alabama • Anaheim, California + 28 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Montgomery", "state": "Alabama" }, { "city": "Anaheim", "state": "California" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01984684" }, { "nct_id": "NCT00426933", "title": "Phase 2 Safety and Efficacy Study of Daptomycin in Complicated Skin and Skin Structure Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Soft Tissue Infections" ], "interventions": [ { "name": "Daptomycin", "type": "DRUG" }, { "name": "Vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA)", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 100, "start_date": "2007-01", "completion_date": "2007-09", "has_results": false, "last_update_posted_date": "2010-09-14", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 1, "location_summary": "Idaho Falls, Idaho", "locations": [ { "city": "Idaho Falls", "state": "Idaho" } ], "official_url": "https://clinicaltrials.gov/study/NCT00426933" }, { "nct_id": "NCT00303589", "title": "A Study of Beta-Lactam in Hospitalized Patients With Skin and Skin Structure Infections", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Soft Tissue Infections" ], "interventions": [ { "name": "Standard care", "type": "DRUG" }, { "name": "beta-lactam", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Hoffmann-La Roche", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 313, "start_date": "2005-12", "completion_date": "2007-10", "has_results": false, "last_update_posted_date": "2016-11-02", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 8, "location_summary": "Birmingham, Alabama • Mobile, Alabama • Melbourne, Florida + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Mobile", "state": "Alabama" }, { "city": "Melbourne", "state": "Florida" }, { "city": "Miami Beach", "state": "Florida" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT00303589" }, { "nct_id": "NCT02378480", "title": "Omadacycline Versus Linezolid for the Treatment of ABSSSI (EudraCT #2013-003644-23)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Bacterial Infections", "Skin Structures and Soft Tissue Infections" ], "interventions": [ { "name": "Omadacycline", "type": "DRUG" }, { "name": "Linezolid", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Paratek Pharmaceuticals Inc", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 655, "start_date": "2015-06", "completion_date": "2016-05", "has_results": true, "last_update_posted_date": "2019-03-21", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 18, "location_summary": "Mobile, Alabama • Chula Vista, California • La Mesa, California + 14 more", "locations": [ { "city": "Mobile", "state": "Alabama" }, { "city": "Chula Vista", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Oceanside", "state": "California" }, { "city": "Santa Ana", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02378480" }, { "nct_id": "NCT02600611", "title": "Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-1", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Skin Structures and Soft Tissue Infections" ], "interventions": [ { "name": "iclaprim", "type": "DRUG" }, { "name": "vancomycin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Motif Bio", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 600, "start_date": "2015-11-01", "completion_date": "2017-01-30", "has_results": true, "last_update_posted_date": "2018-06-19", "last_synced_at": "2026-05-22T02:50:24.080Z", "location_count": 16, "location_summary": "Buena Park, California • La Mesa, California • Long Beach, California + 12 more", "locations": [ { "city": "Buena Park", "state": "California" }, { "city": "La Mesa", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Modesto", "state": "California" }, { "city": "Oceanside", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02600611" } ] }